A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and FF Inhalation Powder in Japanese Subjects With Asthma.
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Fluticasone furoate
- Indications Asthma
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 04 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Dec 2010 New trial record